Skip to main content
Homepage of ProQR
  • We are ProQR
    • About ProQR Therapeutics
    • Founding story
    • Leadership
    • Contact
    • Events
  • Science & Pipeline
    • Science overview
    • Pipeline
    • Axiomer technology
      • How Axiomer and ADAR work
    • RNA therapy
    • Presentations & Publications
    • Partnerships
  • News
    • Press Releases
    • Blogs, stories and news
    • Email alerts
  • Careers
    • Working at ProQR
    • Vacancies
    • Recruitment Experience
  • Investors & Media
    • Investors & Media overview
    • Press Releases
    • Events
    • Corporate presentation
    • Corporate governance
    • Financials and filings
    • Stock info
    • Analyst coverage
    • Contact us
  1. Home
  2. Science & Pipeline
Listen

Presentations & Publications

Share

  • Facebook
  • Linkedin
  • Twitter
  • Whatsapp
  • Email
Axiomer technology

Axiomer RNA editing technology

  • Download link GRC RNA Editing (2025) Platenburg Exploring ADAR RNA editing therapeutic applications pdf, 2.39 MB
  • Download link ProQR Investor & Analyst Event 2024 Presentation pdf, 17.77 MB
  • Download link OTS (2024) Gerard Platenburg Platenburg 2024 OTS - Oligonucleotide guided editing of NTCP for cholestatic diseases pdf, 1.54 MB
  • Download link RNA Editing Summit (2024) Developing Axiomer RNA Editing Technology Towards Clinical Development pdf, 2.83 MB
  • External link ASGCT (2024) Partnership poster, Lilly, Complex Metabolism and Prolonged PK/PD of a GalNAc-Conjugated Editing Oligonucleotide (EON) in Mice
  • External link ASGCT (2024) Gerard Platenburg et al., Robust and Durable RNA Editing In Vivo with Axiomer Editing Oligonucleotides in Non Human Primates
  • External link Deaminet (2024) Gerard Platenburg, Axiomer an RNA editing technology
  • External link RNA Editing Summit (2023) Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability
  • Internal link DATS (2023) Monica Aguila, Exploring the potential of new RNA editing technologies leveraging ADAR endogenous machinery
  • Internal link TIDES USA (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders
  • Internal link Analyst & Investor Axiomer Technology R&D Event (2023)
  • Internal link GRC (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides to Address Liver Originated Disorders
  • Internal link OPT Congress (2023) Gerard Platenburg, Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs)
  • Internal link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines
  • Internal link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines
  • Download link Axiomer™ Technology Overview pdf, 2.25 MB
  • Internal link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position
  • Internal link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing
  • Internal link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes

Share page

  • Facebook
  • Linkedin
  • Twitter
  • Whatsapp
  • Email

You might like this

  • RNA science

    Our antisense oligonucleotides are designed to correct mutations in a person’s RNA. This highly precise approach aims to stop disease progression or even reverse symptoms.

    RNA illustration
  • Working at ProQR - Careers

    We are an innovative biotech company headquartered in Leiden, the Netherlands. We focus on the development of life-changing RNA therapies for severe rare and common diseases. Are you up for a challenge?

    A meeting of ProQRians
  • Press releases

    Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.

    Female scientist working in ProQR's laboratories

Follow us

  • Twitter (opens in new window)
  • Facebook (opens in new window)
  • Instagram (opens in new window)
  • Linkedin (opens in new window)
  • Youtube (opens in new window)
  • Soundcloud (opens in new window)
  • Contact
  • Disclaimer
  • Privacy
  • Sitemap

© 2025 ProQR Therapeutics. All Rights Reserved.

Back to top